Regulation - Research, Markets & Marketing


Popular Filters

Indian pharma threatened by trend of shifting R&D operations overseas: survey


Red tape is putting India's multi-billion dollar worth pharmaceutical industry at risk, with most of…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalRegulationResearch

News briefs: Lexicon's IBS drug; Sanofi Pasteur launch in Thailand; Tranzyme drops TZP-102


US drug developer Lexicon Pharmaceuticals (Nasdaq: LXRX) saw its shares leap 9.1% to $2.04 in premarket…

DiabetesGastro-intestinalsLexicon PharmaceuticalsLX1033Markets & MarketingPharmaceuticalRegulationResearchSanofiSanofi PasteurTranzymeTZP-102Vaccines

Structural defects holding back growth of Russia's pharmaceutical industry


Despite having grown significant since 2009 and set to be worth $10.7 million by 2014, there are some…

EuropeMarkets & MarketingPharmaceuticalRegulationResearch

Medicines Australia sets up new taskforce on transparency for payments to doctors


Medicines Australia has invited the Australian Medical Association, the Royal Australian College of Physicians,…

Asia-PacificFinancialMarkets & MarketingPharmaceuticalRegulationResearch

Russia's pharma industry impresses as economy continues to grow; report


The Russian pharmaceutical industry will continue to expand due to government initiatives and increased…

EuropeMarkets & MarketingPharmaceuticalRegulationResearch

Bayer and Algeta’s Alpharadin efficacy confirmed; Almirall to market Xarelto in Spain


German drug major Bayer (BAY: DE) and Norwegian partner Algeta (OSE: ALGETA) announced that the survival…

AlgetaAlmirallAlpharadinBayerCardio-vascularEuropeMarkets & MarketingOncologyPharmaceuticalRegulationResearchXarelto

Clinical market in CIS to exceed $940 million euros in 2014


Clinical trials in the Commonwealth of Independent States (CIS) countries have been developing in a positive…

EuropeMarkets & MarketingPharmaceuticalRegulationResearch

Drug approval and launch for Novartis in China, where Quintiles expands


Swiss drug major Novartis (NOVN: VX) says it has received regulatory approval in China from the State…

Asia-PacificDiabetesGalvusLucentisMarkets & MarketingNovartisOphthalmicsPharmaceuticalQuintilesRegulationResearch

New studies on Rx drugs: clinical trials reporting; off-label marketing; and use of antipsychotics


US federal rules and regulations related to transparency of prescription drug studies and prohibitions…

Markets & MarketingNeurologicalNorth AmericaPharmaceuticalRegulationResearch

Merck & Co debuts Nexplanon in USA; gets negative FDA response on Zoely and Saflutan


Merck & Co (NYSE; MRK), the USA’s second largest drugmaker, says that its Nexplanon (etonogestrel…

DiabetesJanuviaMarkets & MarketingMerck & CoNexplanonOphthalmicsPharmaceuticalRegulationReproductiveResearchSaflutanZoely

Back to top